Average Co-Inventor Count = 13.05
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Albany Molecular Research, Inc. (1 from 97 patents)
3. Msd Italia S.r.l. (1 from 7 patents)
4. Msd R&d Co., Ltd. (0 patent)
13 patents:
1. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
2. 9840478 - Piperazine derivatives as HIV protease inhibitors
3. 9676780 - [object Object]
4. 9549921 - Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
5. 9549917 - Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
6. 9493461 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
7. 9364482 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
8. 9265773 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
9. 9242998 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
10. 9243002 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
11. 8716312 - Inhibitors of diacylglycerol acyltransferase
12. 8637507 - Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
13. 8232274 - Pyridazinone derivatives useful as glucan synthase inhibitors